The type I interferon system in the etiopathogenesis of autoimmune diseases. - Test2 - elhamkhani - TriplyDB

The type I interferon system in the etiopathogenesis of autoimmune diseases.

The type I interferon system in the etiopathogenesis of autoimmune diseases.

http://www.wikidata.org/entity/Q35514368

about

Clinical perspectives on lupus genetics: advances and opportunities Signal transducer and activator of transcription 4 in liver diseases Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus Drug target prediction and repositioning using an integrated network-based approach Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.Interferon-stimulated genes: a complex web of host defenses.The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus Plasmacytoid dendritic cells in atherosclerosis.Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma.Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines.The genetics of lupus: a functional perspective.IRF5 gene polymorphisms in melanoma B-cell selection and the development of autoantibodies.Expression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in Mexico The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus.Induction of the type I interferon response in neurological forms of Gaucher disease The genetics of scleroderma: looking into the postgenomic era IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature.Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.Type I IFN signature in primary Sjögren's syndrome patients.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.The Role of IFN-alpha in Experimental and Clinical Uveitis.Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells.The multiple pathways to autoimmunity.Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells?Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.Porphyromonas gingivalis RagB is a proinflammatory signal transducer and activator of transcription 4 agonist.New-onset of celiac disease during interferon-based therapy for hepatitis C.A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).Apoptotic-cell-derived membrane microparticles and IFN-α induce an inflammatory immune response.Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies

P2860

Q27001690-8F5444CF-3083-4BB7-AA3D-86F6697B4C70 Q27016571-7E5CF4E8-F14B-4E12-B899-7F5DE7ED6C32 Q28268802-FB90552D-C588-4F08-9631-F2A8E5C80154 Q28485990-136AB9C1-DCE8-4BD8-A707-3F26CA8D1475 Q34106393-E3F63A02-8E55-4EB2-A029-A59642B01EA8 Q34405609-44275B97-A53C-4E96-AD66-B9579ACDF215 Q34634852-EA48853F-6296-44A8-B85B-F853748D0243 Q34796327-41CFD884-8DF1-4C3D-B1B1-7C8E584B0B57 Q35512674-F84D7F6E-989F-489B-95FD-A7A9DC915032 Q36064574-7B0C21D6-063F-4347-AA97-ACF3180DE829 Q36101320-3D3614FE-B8D4-4529-82F6-7DD870DA8F83 Q36108080-660D977D-5A73-44DA-B6A5-5EAAC0EE2F56 Q36245989-1DC0663D-73AF-4902-AD1D-2B41D86E2908 Q36380375-4B9F6F5B-E7D9-432E-95AE-70E25500DBDF Q36504635-9F60D04D-BF41-4BA0-ACAE-5B28C2CC3153 Q36527339-AC3A01C5-686B-49D3-9788-357BFD752982 Q36565949-20702803-55EB-4A6A-9C54-A22D22261444 Q36637528-24B536DE-9E8A-4661-A477-32D39073679C Q36898538-55F72DAE-68D9-4BCE-BBC5-AD5F12FF40EB Q36918205-1B590B0C-0AE3-4019-82A8-82FBB2C116D1 Q37500133-F1A01FC9-A4CF-4556-A866-48AEBB10365C Q37730801-DE82FA8B-719D-4E99-AEA1-DDF7A1344825 Q38023662-B7476321-D70E-4505-9A6F-24F195CDC5EB Q38070990-219F77C3-ED19-42E5-9482-9DB9E9AE9A90 Q38180717-3B91F2AE-0D27-4E8B-BDC4-891C664E5462 Q38335622-675DD614-90AD-4DD4-89AA-A167BD7C57F5 Q38741650-E8638D44-ED92-4087-BE11-A328BBCB9CD8 Q38856516-E164DA9E-2F66-4956-A11C-BA49FA9AD216 Q39384035-899CA5D9-8020-4F98-9F9E-5FAF26B565E9 Q39386100-C4EA7F3D-85EB-4C17-A518-BD18D672D7FC Q39517523-D2EA88EB-7B5B-499E-B291-30438B5D43CE Q40695075-C25E7452-CD6C-41D6-9359-F77558E27AAD Q42154442-4452BE85-92F2-4F8B-B178-ACA4840BB2E8 Q42223192-C0263029-1534-4C0E-A506-26A611ADEE59 Q43143174-EBA26A66-E26B-4F6E-B849-E64E69EE201B Q46055629-A711212F-8866-42F5-88FE-24A39A8F566C Q50852752-E6CD8E91-D13D-4387-B23E-0226BCB6EBC6 Q57018427-A225C023-CB5F-4E06-A4D7-20AE08285420 Q57536946-BA2E0EFC-86E6-4227-B57E-F5E1ED69F715

P2860

The type I interferon system in the etiopathogenesis of autoimmune diseases.

http://www.wikidata.org/entity/Q35514368

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@ast

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@en

type

label

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@ast

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@en

prefLabel

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@ast

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@en

P1433

Q35514368-45F133EF-1C52-481C-AD5F-1252D59F05AB

P1476

Q35514368-640091D6-862C-4497-85E9-1CE625903F08

P2093

Q35514368-3F39A84C-938A-4E16-9E70-23791CCF7402

P275

Q35514368-CE8CA4BD-5281-44AE-A278-27C5B8F68572

P2860

Q35514368-02317BB7-5F98-478D-B931-5380B448A6B4

Q35514368-08B089C1-6E4E-4C39-AD5D-C54FC859C76C

Q35514368-0AF1C3E0-5E66-4F2E-BC0E-240564F20F4C

Q35514368-0C063105-D7B0-4E68-9F76-79D0C1C1BE2D

Q35514368-1341BB01-CB45-407A-ADAF-1BC428413280

Q35514368-1B21FDD3-DD8C-4BE7-8554-98E3B8BD90A6

Q35514368-1BA5E13C-6762-498A-91DE-ACFB1819D0DC

Q35514368-1F32F63A-31DA-448E-9A66-D84C8E69E096

Q35514368-22349B5B-1433-49B3-92BC-ADFA6315E506

Q35514368-259F5706-C26A-4DAA-B4D4-A09FD849683D

P304

Q35514368-78867208-BA9D-444A-AABE-7CF6C2CCE503

P31

Q35514368-AF22D6C7-3CD5-44A7-B186-9D562B1397F6

Q35514368-EA9FFA13-65AC-48D8-80D3-13D55436A809

P356

Q35514368-D26B7E02-B7F6-4F9E-A570-D6FF541B6798

P433

Q35514368-FA0A46FA-67B1-4543-AEEE-20C2634A0371

P478

Q35514368-7A3D5C6D-8346-4AEE-A797-3BEB1A776EF7

P5008

Q35514368-07F7EDBA-9320-4985-8889-0B1E3A1834A5

P577

Q35514368-8A842DDE-B319-464E-BB0E-FFFD55466B22

P5875

Q35514368-3E08CABE-55E2-48BD-AC15-84E25A0B6087

P698

Q35514368-CD786DA9-88F2-48C1-8791-06C30236F75A

P921

Q35514368-BB30B0FD-5AC4-47FF-8C4D-7ACF01EB01AD

Q35514368-FE98170C-9ED3-495D-AC42-7BBFB2C991DA

P932

Q35514368-B25036FF-7B55-4A5B-98AA-802702AB0176

P356

03009734.2011.624649

P1433

Upsala Journal of Medical Sciences

P1476

The type I interferon system in the etiopathogenesis of autoimmune diseases.

@en

P2093

Lars Rönnblom

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

Antiviral actions of interferons

A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

Microarray analysis of gene expression in lupus

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

Virus interference. I. The interferon

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

P304

227-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03009734.2011.624649

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51782995

http://www.w3.org/2001/XMLSchema#string

P698

22066971

http://www.w3.org/2001/XMLSchema#string

P921

autoimmune disease

P932

3207297

http://www.w3.org/2001/XMLSchema#string